Unknown NA INTERVENTIONAL 1-arm NCT05499936

68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC)

Peking Union Medical College Hospital

Sponsor: Peking Union Medical College Hospital

Conditions 68Ga-FAPI PET/CT Metastatic Adenoid Cystic Carcinoma

Interventions 68Ga-FAPI

Updated 4 times since 2022 Last updated: Aug 10, 2022 Started: Oct 1, 2021 Primary completion: Oct 1, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates 68Ga-FAPI PET/CT and Metastatic Adenoid Cystic Carcinoma and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Sep 2022 — Nov 2023 [monthly]

Recruiting NA

First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China